Items where Author is "Adnani, Q. E. S."

(2026) Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Infectious Diseases. pp. 343-361. ISSN 1473-3099

(2026) Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990-2023: a Global Burden of Disease study. Nature Medicine. pp. 1454-1478. ISSN 1078-8956

(2026) Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Oncology. pp. 302-326. ISSN 1470-2045

(2026) Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990-2023: a Global Burden of Disease study. Nature Medicine. p. 46. ISSN 1078-8956

(2026) Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Neurology. pp. 451-468. ISSN 1474-4422

(2026) Updated trends in the global prevalence and burden of mental disorders, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. pp. 2040-2064. ISSN 0140-6736

(2025) Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. pp. 1873-1922. ISSN 0140-6736

(2025) Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019. Nature Communications. p. 36.

(2025) Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023. Lancet. pp. 1731-1810. ISSN 0140-6736

(2025) Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. pp. 1811-1872. ISSN 0140-6736

(2025) Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023. Jacc-Journal of the American College of Cardiology. pp. 2167-2243. ISSN 0735-1097

(2025) Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study. Nature Medicine. pp. 1809-1829. ISSN 1078-8956

(2025) Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Infectious Diseases. pp. 519-536. ISSN 14733099 (ISSN)

(2025) Global, regional, and national burden of asthma and atopic dermatitis, 1990-2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Respiratory Medicine. pp. 425-446. ISSN 2213-2600

(2025) Global, regional, and national burden of suicide, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Public Health. e189-e202. ISSN 24682667 (ISSN)

(2025) Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021. The Lancet Infectious Diseases. pp. 36-51. ISSN 14733099 (ISSN)

(2025) Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet. pp. 813-838. ISSN 0140-6736

(2025) Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. The Lancet. pp. 785-812. ISSN 01406736 (ISSN)

(2025) Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Global Health. E1378-E1395. ISSN 2214-109X

(2025) Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. pp. 235-260. ISSN 0140-6736

(2025) The global, regional, and national burden attributable to low bone mineral density, 1990-2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021. Lancet Rheumatology. E873-E894. ISSN 2665-9913

(2025) The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. pp. 1565-1586. ISSN 0140-6736

(2024) Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet. pp. 2204-2256. ISSN 0140-6736

(2024) Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 1989-2056. ISSN 0140-6736

(2024) Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 2100-2132. ISSN 0140-6736

(2024) Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. The Lancet. pp. 1199-1226. ISSN 01406736 (ISSN)

(2024) Global estimates on the number of people blind or visually impaired by Uncorrected Refractive Error: a meta-analysis from 2000 to 2020. Eye. pp. 2083-2101. ISSN 0950-222X

(2024) Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020. Eye. pp. 2156-2172. ISSN 0950-222X

(2024) Global estimates on the number of people blind or visually impaired by glaucoma: A meta-analysis from 2000 to 2020. Eye. pp. 2036-2046. ISSN 0950-222X

(2024) Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 2057-2099. ISSN 0140-6736

(2024) Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Infectious Diseases. pp. 698-725. ISSN 1473-3099

(2024) Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurology. pp. 344-381. ISSN 1474-4422

(2024) Global, regional, and national burden of neck pain, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatology. e142-e155. ISSN 2665-9913

(2024) Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Neurology. pp. 973-1003. ISSN 14744422 (ISSN)

(2024) Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990-2021: findings from the Global Burden of Disease Study 2021. Lancet. pp. 1955-1988. ISSN 0140-6736

(2024) Temporal patterns of cancer burden in Asia, 1990-2019: a systematic examination for the Global Burden of Disease 2019 study. Lancet Regional Health - Southeast Asia. p. 26. ISSN 2772-3682

(2023) Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019. Eclinicalmedicine. p. 22.

(2023) Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 203-234. ISSN 0140-6736

(2023) Global, regional, and national burden of low back pain, 1990-2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatology. E316-E329. ISSN 2665-9913

(2023) Global, regional, and national burden of meningitis and its aetiologies, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurology. pp. 685-711. ISSN 1474-4422

(2023) Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019. Eclinicalmedicine. p. 23.

(2023) Global, regional, and national mortality due to unintentional carbon monoxide poisoning, 2000-2021: results from the Global Burden of Disease Study 2021. Lancet Public Health. E839-E849. ISSN 2468-2667

(2023) Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990-2021: findings from the Global Burden of Disease Study 2021. Lancet Haematology. e713-e734. ISSN 2352-3026

(2022) Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019. Lancet Public Health. E657-E669. ISSN 2468-2667

(2022) Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019. Lancet Infectious Diseases. pp. 1626-1647. ISSN 1473-3099

(2022) Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA oncology. pp. 420-444. ISSN 2374-2445 (Electronic) 2374-2437 (Print) 2374-2437 (Linking)

(2022) Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncol. pp. 420-444. ISSN 2374-2437 (Print) 2374-2437

(2022) Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. pp. 2221-2248. ISSN 0140-6736

(2022) Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterology & Hepatology. pp. 796-829.

(2022) Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990-2019: results from the Global Burden of Disease Study 2019. LANCET INFECTIOUS DISEASES. pp. 222-241. ISSN 1473-3099 1474-4457 J9 - LANCET INFECT DIS

(2022) Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019. The Lancet Infectious Diseases. pp. 222-241. ISSN 14733099 (ISSN)

(2022) Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. The Lancet. pp. 185-235. ISSN 01406736 (ISSN)

(2022) Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. LANCET. pp. 185-235. ISSN 0140-6736 1474-547X J9 - LANCET

(2022) The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019. LANCET ONCOLOGY. pp. 27-52. ISSN 1470-2045 1474-5488 J9 - LANCET ONCOL

(2022) The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. pp. 563-591. ISSN 0140-6736